0001230439-24-000005.txt : 20240305
0001230439-24-000005.hdr.sgml : 20240305
20240305213929
ACCESSION NUMBER: 0001230439-24-000005
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Ascendis Pharma A/S
CENTRAL INDEX KEY: 0001612042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36815
FILM NUMBER: 24724200
BUSINESS ADDRESS:
STREET 1: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
BUSINESS PHONE: 45 70 22 22 44
MAIL ADDRESS:
STREET 1: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fairey William
CENTRAL INDEX KEY: 0001727275
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O CHEMOCENTRYX, INC.
STREET 2: 850 MAUDE AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
144
1
primary_doc.xml
144
0001727275
XXXXXXXX
LIVE
0001612042
Ascendis Pharma A/S
001-36815
TUBORG BOULEVARD 12
HELLERUP
G7
DK-2900
45 70 22 22 44
Fairey William
Director
American Depositary Shares
Citigroup Global Markets Inc.
390 Greenwich Street
New York
NY
10013
200
29598.00
57707439
03/05/2024
NASDAQ
American Depositary Shares
03/01/2024
Restricted Stock Unit Vesting
Issuer
N
364
03/01/2024
Services Rendered.
Y
The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting.
03/05/2024
William C. Fairey Jr.